Compare Vir Biotechnology Inc. Common Stock (VIR) vs W.R. Berkley Corporation Common Stock (WRB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vir Biotechnology Inc. Common Stock vs W.R. Berkley Corporation Common Stock — how do they compare? Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B), while W.R. Berkley Corporation Common Stock trades at $74.25 (market cap $27.30B). The key difference: W.R. Berkley Corporation Common Stock is far larger — about 15.2× Vir Biotechnology Inc. Common Stock's market cap, and W.R. Berkley Corporation Common Stock pays a 0.54% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vir Biotechnology Inc. Common Stock for 0 Days and W.R. Berkley Corporation Common Stock for 0 Days on average.
| VIR | WRB | |
|---|---|---|
Market Cap | $1.80B | $27.30B |
Volume | 1,782,836 | 2,293,079 |
Sector | Health | Financials |
52-Week High | $11.78 | $78.10 |
52-Week Low | $5.12 | $63.54 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.36B | $27.54B |
Dividend Yield | — | 0.54% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →About W.R. Berkley Corporation Common Stock
W.R. Berkley Corporation is an insurance holding company that underwrites commercial property and casualty insurance and reinsurance through its Insurance and Reinsurance & Monoline Excess segments.
Read more on WRB →
